Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

Condition:   Clostridium Difficile Associated Disease
Interventions:   Biological: Clostridium difficile;   Biological: Placebo
Sponsor:   Pfizer
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days